Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Henrik Stenqvist
Age : 54
Public asset : 1,034,023 USD
Country of residence : Unknown
Linked companies : Swedish Orphan Biovitrum AB (publ) - Dova Pharmaceuticals, Inc. - Calliditas Therapeutics AB (publ) - Midsona AB (publ)

Biography of Henrik Stenqvist 
Presently, Henrik Stenqvist holds the position of Chief Financial Officer at Swedish Orphan Biovitrum AB and Co-Managing Director at Swedish Orphan Biovitrum GmbH (a subsidiary of Swedish Orphan Biovitrum AB). Mr. Stenqvist is also on the board of Midsona AB, Dova Pharmaceuticals, Inc., Swedish Orphan Biovitrum, Inc. and Swedish Orphan Biovitrum Ltd. Henrik Stenqvist previously held the position of Chief Financial Officer & Executive Vice President for Recipharm AB, Chief Financial Officer at Calliditas Therapeutics AB, Finance Director at Astra Export & Trading AB, Chief Financial Officer for MEDA Manufacturing GmbH and Chief Financial Officer, EVP-Finance & Procurement at Meda AB. Henrik Stenqvist received an MBA and an undergraduate degree from the University of Link÷ping.


Current positions of Henrik Stenqvist 
Holdings of Henrik Stenqvist 
Henrik Stenqvist : Personal Network 
Most Read News 
09/26Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
09/20JPMorgan CEO Dimon to warn Congress of economic 'storm clouds' -testimony
RE
09/14Package that exploded in Boston had note critical of Meta's Zuckerberg, CNN reports
RE
09/26Twitter to interview Elon Musk, known for combative testimony
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
09/20Palihapitiya to wind down two blank-check firms as choppy markets deter valuations
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/14Kuehne: have raised stake in Lufthansa to 17.5%
RE
12:05aElon Musk seeks to narrow SEC consent decree, end pre-approval of tweets
RE
09/15Elon Musk accuses Twitter of security lapses in court filing
RE
More news


© 2022 People and Ownership :   
Henrik Stenqvist : Connections 


Latest news about Henrik Stenqvist 
07/19Transcript : Swedish Orphan Biovitrum AB, Q2 2022 Earnings Call, Jul 19, 2022
CI
05/19Calliditas Therapeutics AB Announces Board Changes
CI
04/28Transcript : Swedish Orphan Biovitrum AB, Q1 2022 Earnings Call, Apr 28, 2022
CI
02/10Transcript : Swedish Orphan Biovitrum AB, Q4 2021 Earnings Call, Feb 10, 2022
CI
2021Transcript : Swedish Orphan Biovitrum AB, Q2 2021 Earnings Call, Jul 21, 2021
CI
2021Transcript : Swedish Orphan Biovitrum AB, Q1 2021 Earnings Call, May 04, 2021
CI
2021Transcript : Swedish Orphan Biovitrum AB, Q4 2020 Earnings Call, Feb 18, 2021
CI
More news